Background: It has been widely reported that multisite phosphorylation plays an essential role in the regulation of protein kinases. However, our understanding of how these events modify protein function in vitro and in vivo is poorly understood. Protein kinase C (PKC) affords an interesting example of how phosphorylation control is coupled to effector control. PKC is acutely regulated by the second messenger diacylglycerol; however, it is also known to undergo multisite phosphorylation. Previously, we and others have shown that one site in the 'activation loop' of PKC␣ (a threonine residue at position 497; T497) and PKC␤ (T500) is essential for the catalytic competence of these proteins. More recently, a carboxy-terminal site (T638 in PKC␣) has been implicated. In this report, we investigate the role of this site and its interaction with the catalytic core site.
Background
Protein kinase Cs (PKCs) are a family of serine/threonine protein kinases that are regulated through agonist-induced hydrolysis of membrane phospholipids and are considered to play critical roles in many signal-transduction pathways [1] [2] [3] [4] . The binding of lipid second messengers to PKC triggers a conformational change that displaces the enzyme's autoinhibitory domain, thereby exposing the substrate-binding region [5] . However, in order to phosphorylate its substrates, the kinase first has to be rendered catalytically competent. Growing evidence supports a role for phosphorylation in priming PKC function. In protein kinases, a region linking the two conserved subdomains VII and VIII of the catalytic domain [6] has been identified as an 'activation loop' or 'phosphorylation lip' [7] , according to the known crystal structures of protein kinase A [8] , cyclin-dependent protein kinase [9] and mitogenactivated protein kinase [10] . For many proteins, phosphorylation in this region is critical for function [11] [12] [13] [14] [15] [16] [17] . A threonine residue at position 497 (T497) in the activation loop of PKC␣ has been identified as a critical site for permissive activation -a process that generates a kinase that can be activated by second messengers [13, 18] ; a corresponding site (T500) is present in PKC␤ 2 [16] . Early studies on human breast cancer cells [19] and treatment in vitro with phosphatases [20] have suggested that a PKC kinase is responsible for phosphorylation of this site.
In addition to the permissive phosphorylation at T497 in the activation loop, at least one other functionally relevant phosphorylation takes place in the PKC␣ molecule, at T638, a site now known to be phosphorylated in vivo [21] . It has been reported that phosphorylation at the equivalent site in PKC␤ 1 (T642) and PKC␤ 2 (T641) is essential for activation [21, 22] . Like the PKC␣ mutants lacking phosphorylated T497 [13, 18] , a PKC␤ 1 mutant lacking phosphorylated T642 is inactive [22] . These studies prompted us to unravel the role of both phosphorylations -at the activation loop (T497) and the carboxy-terminal T638 site -in the control and function of PKC␣.
Here, we show that phosphorylation at T497 and T638 are both relevant to the function of PKC␣, but in different, albeit complementary, ways. Phosphorylation at T497 is required for catalytic activity, whereas phosphorylation at T638 is not. Phosphorylation at T638, however, controls the dephosphorylation and inactivation of the enzyme. Furthermore, phosphate groups at both sites cooperate to stabilize the active conformation. These studies, and further proteolytic analysis, suggest a model, which rationalizes interactions between the catalytic domain and the carboxy-terminal part of the PKC␣ molecule; this is likely to be of general importance for other members of the protein kinase superfamily.
Results

One-step purification of PKC␣
To assess the properties of the PKC␣ phosphorylation site mutants, we established a simplified purification procedure that was specific for the recombinant protein expressed in mammalian cells. This was achieved by introducing a histidine tag either at the amino terminus (N-His) or within the hinge region (hinge-His) of PKC␣, which permitted one-step purification on nickel-agarose. As shown in Figure 1 for the purification of wild-type N-His PKC␣, this procedure yielded a highly purified preparation free of the endogenous PKC isotypes. The functional attributes of N-His PKC␣ and hinge-His PKC␣ are entirely consistent with those recorded for purified wildtype PKC␣ (data not shown; but see below). We used N-His PKC␣ for the mutant analyses described here.
Expression and purification of PKC␣ phosphorylation site mutants
In order to analyze the contribution of phosphorylation at position 638, mutations were designed that either prevented phosphorylation (the alanine substitution A638), or might partially mimic phosphorylation by introduction of a carboxyl side chain (glutamic acid substitution E638). The histidine-tagged mutant proteins were expressed in COS-1 cells and purified on nickel-agarose, as illustrated in the western blot shown in Figure 2 . The mutant proteins were efficiently produced in COS-1 cells, although compared with wild-type PKC␣, both mutants were less soluble in detergent. The purified proteins that eluted from nickel-agarose migrated predominantly as 80 kDa species; faster migrating (dephosphorylated) forms were present in the insoluble fraction and the unbound material. The unbound 80 kDa species present in all the samples represents the endogenous COS-1 cell PKC␣. The specific activities of the purified proteins were determined and found to be virtually the same as wild-type PKC␣ ( Fig. 2 ; see also Table 1 ). Thus, phosphorylation at the T638 site is not essential for activity.
The activities of the PKC␣ T638 mutants are unstable in vitro
The modest effects of mutations at the T638 site on solubility and phosphorylation in vivo (as judged by altered migration), suggested that this site plays a subtle role in the regulation of PKC. To investigate this, we carried out a more detailed analysis of the properties of the T638 mutants. The results of this analysis revealed that, in the absence of phosphate at the T638 site, the protein underwent rapid thermal inactivation and was sensitive to oxidation, as detailed below.
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Figure 1
Purification of histidine-tagged PKC␣ after transient expression in COS-1 cells. COS-1 cells, 48 h after transfection with the cDNA encoding the wildtype histidine-tagged PKC␣ cDNA, were lysed in 1 % Triton X-100 and purified as described in Materials and methods. Lane 1 shows the insoluble fraction; lane 2 shows the Triton-soluble extract. This extract was allowed to interact with nickel-agarose beads. Lane 3 shows the Triton-soluble proteins that did not bind to nickel-agarose. Following several washes, bound proteins were eluted with 100 mM imidazole; lane 4. The figure shows a Coomassiestained 10 % polyacrylamide gel, after electrophoresis of comparable amounts of samples. The positions of PKC␣ and the molecular weight markers (in kDa) are indicated. Following storage of the purified A638 mutant at 4°C, it was noted that its activity decayed, whereas the activity of wild-type PKC␣ was essentially stable. This inactivation was greatly exaggerated at higher temperatures ( Fig. 3a) .
At 25°C, the A638 mutant lost activity, with a half-life of less than 10 minutes. In contrast, only about 10 % of the wild-type PKC␣ activity was lost after 30 minutes under identical conditions. Notably, the E638 mutant, where the glutamic acid may partially mimic phosphorylation at this site, showed intermediate stability, with a half-life of approximately 25 minutes. Western analysis of these incubated proteins revealed that as well as the observed inactivation of the mutants, there was an accumulation of more rapidly migrating PKC␣ species (Fig. 3b) . This might reflect dephosphorylation and/or partial proteolysis (see below). No such alterations took place for the wildtype PKC␣.
In order to assess the role of contaminating phosphatases in the inactivation and altered migration, the A638 mutant was incubated in the presence or absence of the phosphatase inhibitor microcystin. As shown in the upper part of Figure 3c , microcystin (lane 4) prevented the altered migration of the mutant protein, indicating that the more rapidly migrating species were dephosphorylated forms. In parallel, ␤-mercaptoethanol was tested for its potential ability to protect against inactivation. As shown in the lower part of Figure 3c , neither ␤-mercaptoethanol (corresponding to lane 3 in the upper panel) nor microcystin (corresponding to lane 4) prevented inactivation under these conditions (but see below). Although microcystin entirely blocked dephosphorylation, its inability to prevent inactivation indicated that a distinct mechanism was responsible for activity loss. Furthermore, the maintenance of the
Figure 2
Expression and purification of PKC␣ 638 site mutants. Wild-type PKC␣ (T638) and proteins with carboxy-terminal mutations (A638 and E638) were transiently expressed in COS-1 cells and purified as in Fig. 1 . Highresolution SDS-PAGE (the region between the 97.4 kDa and 66.2 kDa markers is shown) was followed by western-blot analysis, using a polyclonal antibody raised against the carboxyl terminus of PKC␣; the western blots in all panels were processed together. Direct comparison can be made for all proteins, because equivalent amounts of cells (based upon protein assay of the respective Triton-soluble fractions) were loaded in every lane. In order to detect low amounts of PKC␣, the membranes in the lower two panels were exposed for 5-times longer than the upper two panels. The endogeneous PKC␣, which is the only form seen in the vector-transfected control, does not bind nickel-agarose, and is indicated with an arrow in the third panel. The specific activities, shown under the bottom panel for each PKC␣ preparation, were measured in vitro on the PKC␣ mutants purified on nickel-agarose. Histone was used as a substrate, with mixed micelles of Triton X-100, phosphatidylserine, and TPA, in the presence of calcium, as described in Materials and methods. Activity of the wild-type enzyme was in the range of 5-20 mol mg -1 min -1 at 25°C. In the absence of cofactors, there was no activity associated with either the wild-type or any of the mutant proteins (data not shown). Values shown represent the mean of five (E638, A638) independent determinations (see also Table 1 The specific activities of activation-loop and T638 site mutants.
Activation loop
Carboxy-terminal Relative specific activity 494, 495, 497 638 (mean ± SEM) TTT* T* 100 TTT E 71 ± 17 TTT A 74 ± 13
The mutant proteins indicated by the amino acids at residues 494, 495, 497 and 638, were transiently expressed in COS-1 cells and purified by nickel-agarose affinity chromatography, as described in Materials and methods. The activities were determined directly using histone as a substrate (see Materials and methods). These activities are expressed as a function of PKC␣ antigen and presented relative to the wild-type activity (5-20 mol min -1 mg -1 ) determined in parallel in each of five (E638, A638), three (E497) or two (AAE) independent experiments. Values are means and SEM. For the TTE/E mutant, specific activity was determined in one experiment only. In the case of the mutants TTE/A, AAE/E and AAE/A, no antigen was recovered upon affinity purification on nickel-agarose, and activities were determined for the unpurified proteins. *Wild-type protein.
80 kDa antigen in the presence of ␤-mercaptoethanol and microcystin demonstrated that proteolysis was not responsible for loss of activity. It should be noted that ␤-mercaptoethanol had a protective effect upon antigen loss (compare Fig. 3c , lanes 2 and 3), and slowed the rate of dephosphorylation.
Protection of PKC␣ T638 mutants from inactivation
The subtle effects of ␤-mercaptoethanol suggested the possible involvement of oxidation in one pathway of PKC␣ inactivation. At lower temperatures (below 22°C), the effects of the reducing agents were more apparent. At 4°C, ␤-mercaptoethanol (data not shown) and dithiothreitol (DTT) protected the PKC␣ A638 mutant for several hours (Fig. 4a ). Wild-type PKC␣ remained active in the presence and absence of reducing agents (data not shown). This protective effect indicated that the sulphydryl group of a critical cysteine residue is exposed in the A638 mutant and is sensitive to oxidation. In protein kinase A (PKA), alkylation of C199 induces inactivation [23] [24] [25] [26] ; this cysteine residue lies close to a threonine at position 197, the activation loop phosphorylation site in PKA. In PKC␣, the equivalent phosphorylation site (T497) is similarly juxtaposed with a cysteine residue (C499). The binding of adenylyl nucleotides to the ATP-binding site of PKA prevents alkylation of C199 [23, 24] . To determine whether the sensitive sulphydryl in PKC␣ behaved similarly, we investigated the effects of nucleotides on its inactivation. We found that Mg-ATP and Mg-ADP could fully protect PKC␣ A638 from inactivation at 25°C (Fig. 4b) ; Mg-AMP or ATP alone afforded no protection. It should be noted that autophosphorylation of PKC␣ is not seen in the absence of lipids; hence, under these conditions, Mg-ATP was not 'protecting' by increasing phosphorylation. This was further suggested by the finding that the A638 mutant was also fully protected by Mg-ADP. The sulphydryl sensitivity is consistent with C499 being more sensitive to oxidation in PKC␣ A638 than in the wild-type protein, indicating that lack of phosphorylation of T638 leads to exposure of this cysteine.
PKC␣ T638 mutants are supersensitive to protein phosphatases both in vitro and in vivo
The dephosphorylation of PKC␣ A638 but not wild-type PKC␣ (see Fig. 3b ) suggested that this mutant might be more sensitive to phosphatases -that is, its sites were more available than those of the wild-type protein. Protein phosphatase 1 (PP1) has been shown to dephosphorylate and inactivate PKC␣ [20] and PKC␤ [27] in vitro. In order to avoid any contribution from contaminating phosphatases, the dephosphorylation of wild-type PKC␣ and PKC␣ A638 was tested with excess PP1 and with purified PKC␣ proteins bound to nickel-agarose (Fig. 5) . Under conditions where the first fast-migrating species of wildtype PKC␣ was just visible (lane 2), PKC␣ A638 was fully shifted to its fastest migrating form (lane 4). The E638 mutant was analyzed in parallel and was also supersensitive to PP1 (compare lanes 5 and 6). Thus, lack of phosphate at the T638 site correlates with sensitivity to dephosphorylation at the remaining sites.
Recent studies from this laboratory have shown that, in vivo, dephosphorylation of PKC␣ takes place in a membrane compartment following activation by TPA (12-Otetradecanoyl phorbol-13-acetate; G. Hansra, F.B., R. Whelan and P.J.P., unpublished observations). In order to determine the sensitivity of the A638 mutant in vivo, its dephosphorylation was monitored by altered migration following treatment of transiently transfected COS-1 cells with TPA. The data in Figure 6 show a profound difference between wild-type PKC␣ and the PKC␣ A638 mutant. The dephosphorylation of the mutant started (as judged by its migration) no later than 5 minutes after the addition of TPA, and by 15 minutes, the entire pool of A638 had been converted into its fastest running species. The E638 mutant was tested in parallel and behaved in essentially the same way; dephosphorylation in this case was complete by 30 minutes (data not shown). In contrast, treatment with TPA for 1 hour did not lead to significant dephosphorylation of wild-type PKC␣. In conclusion, the absence of phosphate at T638 sensitizes PKC␣ to phosphatases both in vitro and in vivo
Sensitivity of the A638 mutant to proteolysis
The data above are consistent with the notion that phosphorylation at the T638 site induces a closed conformation of PKC␣; conversely, lack of phosphate at this site favours an open conformation (see Discussion). To test potential conformational differences, trypsin sensitivity was compared for the wild-type and A638 PKC␣ proteins. Wildtype PKC␣ showed a characteristic, time-dependent loss of full-length antigen with a concomitant, transient accumulation of a 47 kDa catalytic domain fragment (Fig. 7) . In contrast, the A638 PKC␣ mutant was very rapidly degraded by trypsin, without any significant accumulation of an immunoreactive 47 kDa species.
Functional interaction between T638 and T497 sites
The properties of the T638 site, in particular the effects of ATP on stability and on protecting the cysteine residue from oxidation, indicated that there may be an interaction between this carboxy-terminal region and the catalytic core, and that this interaction underlies the mechanism by which T638 phosphorylation controls these properties. In order to investigate this issue, we determined how this site operates in the context of alterations to the T497 site in the catalytic core; it has been established that the latter is essential for activity. Because alanine substitution at position 497 renders the protein completely inactive [18] , we tested mutant proteins with glutamic acid substitutions, with or without alterations to the proximal threonine Increased sensitivity of PKC␣ A638 to oxidation and protection by nucleotides. (a) A sample of purified PKC␣ A638 was assayed for kinase activity immediately after elution from nickel-agarose (t = 0). The sample was split into two aliquots, one of which was supplemented with 5 mM DTT. Both samples were kept on ice and assayed for residual kinase activity after the times shown. The graph shows the time course of the activity of the sample with no added DTT, plotted as a function of the activity in the presence of DTT. There was no activity loss in the sample supplemented with DTT during the course of the experiment (data not shown). (b) A sample of purified PKC␣ A638, supplemented with 10 M microcystin, was incubated at 25°C for 30 min in the presence (+) or absence of one or more of the following: 5 mM MgCl 2 , 5 mM EDTA, 50 M ATP, ADP or AMP. A control treatment was also included, where ATP was added at t = 30 min rather than t = 0 min (-/+). After the incubation, activity was measured and compared to that of an aliquot of the same sample kept on ice, without any addition (100 %). Values shown represent the mean of two or three independent measurements (+ S.E.). ATP was also effective at 20 M, which is around the K m value for PKC␣ [41] ; AMP was ineffective, even at 1 mM (data not shown). Increased sensitivity of PKC␣ A638 and E638 to PP1 in vitro. Wildtype PKC␣ and the A638 or E638 mutants were purified after transient expression in COS-1 cells, but were not eluted from nickel-agarose. An equal volume (30 l) of PP1 dialysis buffer (see Materials and methods) or PP1 (100 units ml -1 ) was added to these nickel-agarosebound PKC samples. The mixed sample was diluted twice in PKCpurification buffer (see Materials and methods) and the reaction was allowed to proceed for 2 h at 22°C with continuous stirring. Samples were then subjected to SDS-PAGE and immunoblotting, as above.
residues, which further compromise activity. As indicated in Table 1 , mutation of the activation-loop site sensitizes the protein mutated at the 638 site to loss of activity. Thus, although both the TTE/T and AAE/T PKC␣ mutants showed residual activity (23 % and 6 % of wildtype PKC␣, respectively), when combined with an alanine mutation at position 638, the proteins were inactive.
These observations demonstrate that there is a functional interaction between the catalytic core site (residue 497) and the carboxy-terminal site (residue 638). In view of the properties of the T638 phosphorylation site mutants described above, and the interaction between the T638 and T497 sites, it was pertinent to determine whether these properties were local (related to T638 only), or global (related to T638 and T497). To this end, the activity of the E497 mutant was assessed for thermal stability and phosphatase sensitivity. Like PKC␣ A638, PKC␣ E497 was thermally unstable (Fig. 8a) and had a half-life of less than 30 minutes at 25 ºC. PKC␣ E497 was also much more sensitive to PP1 than wild-type PKC␣ (Fig. 8b) . Furthermore, when the E497 mutant was transiently expressed in COS-1 cells, TPA treatment for 15-30 minutes induced its rapid dephosphorylation (Fig. 8c) . Thus, the activation-loop mutant E497 behaved like the carboxy-terminal mutant A638 (or E638), consistent with the functional interaction identified for these phosphorylation sites.
Discussion
The evidence presented here demonstrates that phosphorylation at the T638 site in PKC␣ has no effect upon catalytic activity in its own right, but acts to control the sensitivity of the protein to dephosphorylation and inactivation. This effect is readily observed in vitro, with PP1, and in vivo, following stimulation with TPA. The molecular basis of this control is reflected in the properties of the 638 site mutants and their functional relationship to the catalytic core phosphorylation site (T497). Thus, the thermal inactivation, oxidation sensitivity, trypsin sensitivity and phosphatase supersensitivity are all compatible with the view that phosphorylation at position 638 stabilizes a 'closed' protein conformation (see model in Fig. 9 ), in which the phosphorylation sites and sensitive cysteine are not exposed to phosphatases and oxidants, respectively. The finding that mutations at this carboxy-terminal site and the catalytic core site (T497) act cooperatively to cause loss of activity, implies that the closed conformation involves the interaction between the carboxy-terminal region and the catalytic core. This supposition is strongly supported by the finding that the E497 mutant, like the E/A638 mutants, is thermolabile and supersensitive to PP1 in vitro and similarly supersensitive to agonistinduced dephosphorylation in vivo.
Previous studies on the role of the 642 site in PKC␤ (the equivalent of the 638 site in PKC␣), using site-directed mutagenesis, had indicated that phosphorylation of this site is required for catalytic activity [22] . A similar conclusion was reached by differentially dephosphorylating the purified protein [21] . These observations contrast with the current data, which demonstrate no intrinsic requirement for the equivalent phosphorylation event in PKC␣. Although this difference may reflect the analysis of distinct PKC isotypes, it seems more probable that there is a common process involved. The most likely explanation for the different interpretations is that little consideration has A638 PKC␣ is hypersensitive to proteolysis. Wild-type and A638 PKC␣ were purified as described in Materials and methods. The proteins were subjected to limited proteolysis with trypsin for the times indicated. Proteins were then separated on 12.5 % SDS-PAGE gels and immunoblotted for PKC␣ using a carboxy-terminal-reactive serum.
In both panels, the intact PKC␣ (80 kDa) is indicated by an arrowhead. The catalytic domain fragment (47 kDa) generated from wild-type PKC␣ is indicated by the arrow. An acidic residue at position 638 produces a PKC␣ mutant with a phenotype intermediate between that of wild-type and A638 PKC␣. This implies that such acidic mutations only partially mimic phosphorylation. Similar partial effects are seen for mutations at the T497 site (the E497 mutant has only 22 % of the activity of wild-type protein). This compromised activity provided the means by which a functional interaction between the T497 and T638 sites could be demonstrated. Thus, in the context of an E497 mutation, the requirement for phosphorylation at the 638 site becomes more stringent. The mechanism of this interplay between sites probably involves a physical association between the carboxy-terminal domain and the catalytic core. This conclusion corroborates structural studies, which propose that the carboxy-terminal region wraps across the catalytic core with the phosphate in the 638 site making contact with a basic cluster in the smaller, upper lobe of the kinase domain [28] .
Empirical evidence for the carboxyl terminus 'masking' the activation loop of PKC␣ is provided by the finding that thiol-reducing agents are able to inhibit inactivation of the Similarities between PKC␣ proteins with mutations in the activation loop (E497) and the carboxyl terminus (A638), both in vitro and in vivo. (a) The thermolability of the PKC␣ E497 mutant compared with that of A638 and wild-type PKC␣ was determined as described in Fig. 3a . After 30 min at 25°C, the activity of PKC␣ E497 had decayed by more than 50 % (data not shown). (b) In vitro treatment of E497, A638 and the wild-type PKC␣ with PP1 was performed as described in Fig. 5 , except that PKC␣ was eluted from nickel-agarose. A time course was performed up to 120 min. This figure shows the 30 min time point, after SDS-PAGE and immunoblotting. At t = 120 min, the wild-type enzyme had not yet been dephosphorylated, whereas the dephosphorylation of E497 had gone to completion (data not shown). (c) The E497 mutant was treated with TPA in vivo, and analyzed as described in Fig. 6 . 
Figure 9
Model for the role of phosphorylation in determining contacts between the catalytic domain and the carboxyl terminus of PKC␣. Wild-type PKC␣ in its latent state has two conformers in dynamic equilibrium; in the closed conformation, the active site in the conserved (C3/C4) region of the catalytic domain and the carboxy-terminal part of the variable (V5) region of PKC, interact; in the open conformation they do not interact. When both T497 in the active site and T638 in the V5 domain are phosphorylated (red), PKC␣ essentially remains in the closed conformation. The sulphydryl group (SH) of C499 is buried and the protein is resistant to phosphatases. If PKC lacks phosphate on either T638 or T497 (whether as a consequence of not being phosphorylated, or being dephosphorylated), the equilibrium is shifted towards the open conformation. In that state, other phosphorylation sites in the protein are accessible to phosphatase attack, the sulphydryl group of C499 is exposed, and the protein inactivates rapidly in vitro. A638 mutant. This raises the possibility that a cysteine side chain critical for activity becomes exposed; this is reminiscent of PKA. In this protein, two cysteine residues can be covalently modified, and for one of them, C199, this leads to loss of activity [23] [24] [25] [26] . This cysteine happens to lie in the activation loop of PKA, just two residues away from the critical phosphorylation site, T197. Several studies, including the solution of the crystal structure of PKA [8] , have shown that C199 is near the active site, next to the ␥-phosphate of ATP. PKC␣ also contains an equivalent cysteine residue (C499), located similarly in the activation loop. We have shown that ADP and ATP prevent inactivation of the A638 mutant. In a comparable manner, ATP protected C199 in PKA from sulphydryl-reactive agents, thereby preventing loss of activity [23, 24, 26] . One interpretation that is consistent with these findings is that in the A638 mutant, C499 is exposed and readily oxidised, whereas in the wild-type protein it is buried.
The two phosphorylation sites analyzed in this study are well conserved in the PKC superfamily. All PKC isotypes identified so far, together with the recently identified PRK family (protein kinase C-related kinases) [29, 30] , contain this pair of phosphorylation sites equidistant from each other. Outside the PKC superfamily, a similar phosphorylation pattern can also occur. For example, as for PKC, the distance between the two sites is conserved in PKA, where the phosphorylated residues are T197 (activation loop) and S338 (carboxyl terminus) [31] [32] [33] . The crystal structure of PKA indicates that S338 is in close proximity to the ATP-binding region [8] . A similar location of T638 in the structure of wild-type PKC␣ would be consistent with the observation that Mg-ATP can fully protect the A638 mutant from inactivation. In PKA, stabilization of the active structure through phosphorylation of S338 has not been documented; however the carboxyl terminus of PKA contains many acidic residues in the neighbourhood of S338, which might already provide a substantial contribution towards anchoring the carboxyl terminus appropriately.
This study provides the first evidence of dephosphorylation as an important means of regulating PKC in vivo. It has been shown that dephosphorylation of a defined site in the active, membrane-associated PKC molecule is a rate-limiting step leading to exposure and dephosphorylation of other sites. Serine 657, the third phosphorylation site in the kinase domain of PKC␣ [21] , seems to be one of the sites cooperatively uncovered and dephosphorylated (F.B. and P.J.P., unpublished observations). A site equivalent to S657 is also phosphorylated in vivo in PKC␤ [21, 34] , and turns out to be well conserved not only in the PKC family, but also in proteins like S6 kinase (p70 s6k ), in which the distance between this site and the catalytic core is the same as that for PKC␣. In p70 s6k , the dephosphorylation of this site is the principal event in the inactivation induced by the immunosuppressive agent rapamycin [35] . The properties and the mechanism of dephosphorylarion control proposed here for PKC␣ is likely to be of general significance to p70 s6k and other protein kinases that retain phosphorylation sites in their equivalent carboxy-terminal regions. The prediction is that the phosphorylation state of these carboxy-terminal sites will affect the dephosphorylation of the catalytic core sites in the activation loops, thus controlling the activities of the proteins.
Conclusions
The data presented here provide the basis for a model of PKC␣ action, wherein newly synthesised PKC␣ accumulates phosphate in multiple sites, including residue 497, which is essential for activity. On agonist-dependent activation at the membrane, the protein is dephosphorylated, and the rate of dephosphorylation of the active form is tightly controlled by the extent of phosphorylation of the T638 site. Agents that influence the steady-state level of T638 phosphorylation will have a marked effect upon the maintenance of active, membrane-associated PKC.
Materials and methods
Mutagenesis
The cDNA sequence of bovine PKC␣ [36] was modified by introducing six histidine codons at the third codon after the initiator methionine codon, producing N-His PKC␣. To this end, the sequence of PKC␣ between the NcoI site (position 50) and the XmaIII site (position 68) was substituted for a linker resulting from the annealing of the two following oligonucleotides: sense, CATGGCTCATCACCATCATCAC-GACGTCTTCCC; antisense, GGCCGGGAAGACGTCGTGATGGT-GATGGTGATGAGC. The nucleotide sequence encoding N-His PKC␣ was subcloned into the pKS1 [37] vector as a SacII-XhoI fragment. Mutations were introduced in the bovine PKC␣ cDNA using the Altered Sites in vitro mutagenesis system (Promega). An EcoRI-XbaI fragment containing the full coding sequence of PKC␣ was cloned into the pAlter-1 vector. In addition to the ampicillin repair oligonucleotide, the following mutagenic oligonucleotides, which are sense with respect to the PKC␣ cDNA, were used (changed bases are underlined): T497E, ATGGACGGCGTCACGACCAGGGAGTTCTGCGGGACC; T494A/T495A/T497E, ATGGACGGCGTCGCGGCCAGGGAGTTC-TGCGGGACC; T638A, GGGCAGCCTGTCTTGGCGCCGCCC-GACCAGCTG; T638E, GGGCAGCCTGTCTTGGAGCCGCCCGA-CCAGCTG.
Mutant sequences were validated by sequence analysis using the Sequenase version 2.0 DNA sequencing kit (USB). Either a Bal1-Xba1 fragment (corresponding to amino acids 17-672) or a Sma1-Xba1 fragment (corresponding to amino acids 578-672) from pAlter-1 plasmids containing the different PKC␣ mutants, were ligated to a pKS1-N-His PKC␣ plasmid, restricted with the corresponding enzymes, in order to create the different pKS1-N-His PKC␣ construct.
Purification of PKC␣ after transient expression in COS-1 cells
COS-1 cells were maintained in Dulbecco's modified Eagle's medium containing 10 % (v/v) fetal-calf serum, 1000 units ml -1 penicillin and 100 g ml -1 streptomycin. 50 g plasmid pKS1, or pKS1-N-His PKC␣, encoding wild-type or mutant PKC␣ proteins, was introduced into 0.8 ml of 60-80 % confluent COS-1 cells (5 × 10 6 cells) by electroporation (0.45 kV for 8-10 msec) . After 48 h of transient expression, the cells were lysed in 500 l of an ice-cold lysis buffer containing 20 mM Tris-HCl (pH 7.5), 120 mM NaCl, 1 % (v/v) Triton X-100, 2 mM ␤-mercaptoethanol, 5 mM benzamidine, 50 g ml -1 leupeptin, 50 g ml -1 aprotinin, 50 g ml -1 trypsin inhibitor, 5 g ml -1 pepstatin, 1 mM phenylmethysulfonyl fluoride, 20 mM NaF, 1 mM Na 3 VO 4 , 1 mM para-nitrophenylphosphate and 5 mM imidazole. The suspension was subjected to 20 strokes in a Dounce homogenizer and centrifuged at 12 000 × g for 30 min at 4°C. The supernatant (Triton-soluble extract) was tumbled for 1 h at 4°C after adding 30 l of a nickel-NTA-agarose slurry (nickel-agarose) (Qiagen). After a short spin, the supernatant (unbound material) was removed and the beads (bound material) were washed 3-5 times in 500 l of lysis buffer. The last pellet was finally tumbled for 1 h at 4°C in 500 l of lysis buffer (1 % Triton for Fig. 3, 0 .02 % Triton otherwise) containing 100 mM imidazole, in order to elute the histidine-tagged PKC from the beads. The Triton-soluble and Triton-insoluble fractions were mixed with 5× Laemmli buffer [40] and subjected to SDS-PAGE.
Treatment of COS-1 cells with phorbol esters
Plasmid DNA was introduced into COS-1 cells as described above. After 30h of transient expression, the medium was changed and 500 nM TPA was added. At various time points, the incubation medium was removed, cells were quickly rinsed in ice-cold PBS and lysed in lysis buffer (same as above but without imidazole) supplemented with 10 M microcystin. The lysate was passed twice through a 27-gauge needle and centrifuged for 20 min at 12 000 × g at 4°C.
Treatment of purified PKC with PP1
The ␥ isoform of PP1 [38] was obtained as a recombinant protein after introduction of the pCW PP1 plasmid into competent Escherichia coli DH5␣. Expression and purification were carried out as described in [39] . The final fractions, containing phosphatase activity, were pooled, dialysed overnight at 4°C against 25 mM triethanolamine-HCl (pH 7.5), 0.02 % (v/v) Triton X-100, 1 mM MnCl 2 , 2 mM ␤-mercaptoethanol, 50 % (v/v) ethyleneglycol, and stored at -20°C. For PKC samples to be subjected to PP1 treatment, the last washing and the elution steps (see above) were performed in the absence of NaF, Na 3 VO 4 and para-nitrophenylphosphate. Treatment of PKC with PP1 took place at 22°C with PKC either bound to (Fig. 5 ) or eluted from (Fig. 8b) nickel-agarose, in the presence of 1 mM MnCl 2 . The reaction was stopped by adding 10 M microcystin.
Protein assays and analysis
For determination of PKC activity, each PKC sample (10 l) was mixed with 30 l of a solution containing 5 mM Hepes, 0.2 % Triton X-100, 150 mM KCl, 2 mM MgCl 2 , 2 mg ml -1 substrate (histone III-S, or protamine sulfate) and 200 M ␥-[ 32 P]ATP. After 3 min at 25°C, 20 l of the mixture was removed and spotted on P81 phosphocellulose filters (Whatman). Filters were washed three times in 30 % acetic acid and counted. When histone III-S was used as a substrate, Triton X-100 was present as mixed micelles containing 1 g ml -1 TPA and 1 mg ml -1 phosphatidylserine, in the presence of 0.1 mM CaCl 2 (final concentrations).
Protein concentrations were determined by the bicinchoninic acid method (Pierce Chemical Co.), using bovine serum albumin as the standard. SDS-PAGE was performed on samples diluted twice in 5× Laemmli buffer [40] , using 12 cm long running gels containing 7.5 % acrylamide and 0.06 % bisacrylamide, except for Fig. 1 (10 % acrylamide, 0.27 % bisacrylamide) and Fig. 7 (12.5 % acrylamide, 0.33 % bisacrylamide). When required, the gel was transferred onto nitrocellulose, and subjected to immunoblotting using a polyclonal antibody raised against the carboxyl terminus of PKC␣ [41] . The secondary (peroxidase-linked donkey anti-rabbit) antibody as well as the ECL westernblotting detection system were from Amersham. All reproductions of gels and autoradiographies were obtained as computer-scanned images.
Limited proteolysis of wild-type and A638 PKC␣ was carried out using 10 g ml -1 trypsin at 30°C, in a final volume of 30 l containing 20 mM Tris-HCl (pH 8.0), 15 mM ␤-mercaptoethanol, 0.5 M microcystin, 0.02 % (v/v) Triton X-100 and 0.6 units of PKC␣. Proteolysis was terminated by adding 10 l of 0.4 mg ml -1 trypsin inhibitor. Samples were subsequently boiled in 0.3 volumes of 4× sample buffer and then subjected to SDS-PAGE.
